Do implants need replacing every 10 years? Real lifespan, check-ups and exchange

No. The ten years is a popular rule, not a medical indication, and there is no expiry date printed on a breast implant.

But the full answer is not “so they last forever”, which is the other extreme and also false. This page explains what the regulator says about how long they last, what check-ups are appropriate, when they are replaced and what happens if you decide to have them out and put nothing back.

Where the ten-year myth comes from

From a twisted reading of a real figure.

Manufacturers offer product warranties that usually have a time horizon. And follow-up studies are designed with cut-off points at five and ten years, because they have to be put somewhere. From there to “they have to be changed at ten years” is a leap nobody makes explicitly and everybody has heard.

🔑 What is true about the ten-year mark: it is the point at which follow-up series begin to record a significant number of further operations. That is not an indication to replace: it is a description of what happens.

What the FDA does say

It is worth quoting in full because it is more nuanced than is reported in either direction:

“Breast implants are not considered lifetime devices. The longer a person has them, the greater the chances of developing complications. Some complications will require more surgery. There is no guarantee that a satisfactory cosmetic outcome will be achieved with any further surgery.”

And it adds: the life of a breast implant varies from person to person and cannot be predicted.

Three things in one paragraph:

1. They are not permanent, even though they do not expire.
2. The risk accumulates over time, it does not arrive all at once on a given date.
3. ⚠️ A second operation does not guarantee a good cosmetic result. It is the sentence least often quoted and the one most worth bearing in mind before considering an elective replacement.

The figures that go with that, from the manufacturers’ follow-up studies: 20–40% further surgery in the first 8–10 years, and as many as 1 in 5 having the implant removed within the first ten years.

Why there are check-ups even without a replacement

Here is the real reason, and it has nothing to do with expiry.

Rupture of a silicone gel implant is usually silent. The FDA describes it this way:

“Most ruptures of silicone implants are asymptomatic, which is known as ‘silent rupture’. A silent rupture usually does not change the appearance or feel of the implant, and your surgeon or healthcare provider may not be able to detect it by physical examination alone.”

🔑 Translated: there is no symptom to warn you, and touching the breast does not detect it. That is why follow-up is by imaging and not by sensation.

Occasionally it does give signs: a decrease in the size of the breast, a change in shape, hard lumps over the implant or on the chest, an uneven appearance between the two breasts, pain or tenderness, tingling, swelling, numbness, burning or changes in sensation. Any of these is a reason to be seen.

The schedule

The minimum the FDA sets out:

• A first imaging test at years 5 to 6 after surgery.
• Then every 2 or 3 years.
• MRI is the most effective method for detecting a silent rupture.
• Ultrasound is an acceptable alternative for screening in patients without symptoms — a change the FDA introduced in December 2023.

ICPM’s standard is tighter: an annual breast ultrasound. It serves two purposes at once: monitoring the state of the implant and the capsule, and examining the breast tissue itself. The ultrasound is not carried out at our centre: it is done wherever is most convenient and the result is reviewed at the follow-up appointment.

⚠️ And a point that is constantly confused: the implant check ultrasound does not replace screening mammography, or the other way round. It is explained in the page on living with implants.

When an implant is replaced

For a reason, not on a date. The five usual ones:

1. Rupture. Confirmed by imaging or suspected from symptoms. When the gel escapes but stays inside the capsule it is called an intracapsular rupture; if it passes through, extracapsular; and if it migrates to distant areas, extracapsular with gel migration. ⚠️ The FDA warns that silicone can be difficult to remove after a rupture, which is an argument for not leaving a known rupture.

2. Grade III or IV capsular contracture. That is, the kind that leaves the breast firm or hard and abnormal in appearance. Grades I and II do not usually require surgery. ⚠️ And it is worth knowing that it can happen again after the surgery that corrects it.

3. Malposition or displacement. The implant is no longer where it should be, through gravity, injury or contracture.

4. A change in the result. The breast has changed around the implant — through pregnancy, weight or time — and the whole no longer works.

5. Because the patient wants something different. Changing volume or shape is a legitimate reason, and it is elective surgery with all its risks. This is where the FDA’s warning that no further surgery guarantees a satisfactory result weighs most.

And one more, uncommon but categorical: a confirmed BIA-ALCL. In that case the FDA indicates that what is required is removal of the implant and the surrounding capsule, a more extensive operation than removal alone. It is in its own page.

What is NOT a reason to replace

• That ten years have passed.
• An unconfirmed rupture in someone without symptoms and with normal imaging.
• Generalised fear. The FDA is explicit: it does not recommend the routine removal of implants in patients without symptoms.

What a replacement actually is

It is a new operation, not a formality. It has its own anaesthetic, its own recovery and its own risk profile, and there are two decisions taken separately:

What is done with the implant. It is removed and replaced, or removed without being replaced.

What is done with the capsule. The FDA describes two methods:

• Removing the implant alone and leaving the capsule. This requires less surgical dissection and may carry less risk of local complications, such as bleeding or damage to neighbouring tissue.
• Removing the capsule as well, in part or completely. This is what is called en bloc resection, removal with total or partial capsulectomy. It is a more extensive operation.

🔑 The house standard: in general the capsule is always removed. The exception is a capsule that is very thin, healthy, non-pathological and elastic, where part of it may be left in order to minimise damage to the tissues. But it is a decision for each case, and it is taken with the capsule in front of you.

⚠️ The FDA does not recommend one by default: it says to discuss with your surgeon which is best in each situation. A confirmed diagnosis of BIA-ALCL does change the answer.

And if I have them out and put nothing back

It is a legitimate decision and an increasingly common one, and it deserves to be described plainly.

The FDA puts it this way: some women who do not replace their implants may have dimpling, hollowing of the chest wall, puckering or sagging of their own breasts, a cosmetically undesirable result. And it adds the point that matters most:

⚠️ “Women with large implants, especially those placed in front of the chest muscles (subglandular), may have significant cosmetic deformity if they choose not to replace them or not to undergo additional reconstructive surgery.”

This is information, not an argument against explanting. There are options for improving that result — a lift, a fat graft — and they are decisions taken knowing the above.

Is it done here, and with what options?

Yes. Both replacement and removal of implants are carried out here, and reconstruction is planned according to what each case needs. The tools are these, alone or combined:

• Mastopexy, to reposition the breast when what remains has descended.
• Fat transfer, to restore volume and soften contours with your own tissue.
• Adjusting the breast pocket, when the space where the implant sat has been left distorted or too large.

They are not a package: they are recommended according to what is needed, and in many cases none of them is.

The financial detail worth knowing

Another verbatim sentence from the FDA:

“Some insurance companies do not cover implant removal or replacement, even if there are complications and even if the first implant surgery was covered.”

What the price of an augmentation includes here — and follow-up appointments are inside it — is in what you will sign and what you must be given.

Frequently asked questions

Do breast implants need replacing every 10 years?

No. There is no expiry date and a replacement is decided for a specific reason — rupture, grade III or IV contracture, malposition, a change in the result or the patient’s wish — never by the calendar.

So do they last forever?

No. The FDA states that implants are not lifetime devices and that the longer they are worn the greater the likelihood of complications requiring more surgery. In the follow-up studies, between 20% and 40% of patients had further surgery in the first 8–10 years.

What check-ups do I need?

The FDA places the first imaging test at years 5 to 6 and every 2 or 3 years thereafter, with MRI as the most effective method and ultrasound as an acceptable alternative in patients without symptoms. At ICPM we recommend an annual breast ultrasound, carried out outside the centre and reviewed at the follow-up appointment.

Would I notice if an implant ruptured?

Often not. Most silicone ruptures are silent: they do not change the appearance or feel of the breast, and even a physical examination does not detect them. That is why follow-up is by imaging.

Is it dangerous to have a ruptured implant?

What the FDA notes is that the gel may stay inside the capsule, pass through it or migrate to distant areas, and that it can be difficult to remove afterwards. That is the practical reason not to postpone a confirmed rupture.

Is a replacement a simpler operation than the first one?

It is a new operation, with its own anaesthetic and recovery, and with two decisions of its own: what is done with the implant and what is done with the capsule. The FDA also warns that no further surgery guarantees a satisfactory cosmetic result.

How does the breast look if I have the implants out and do not put others in?

It may be left with dimpling, hollowing, puckering or sagging, according to the FDA, and the effect is more marked if the implants were large and placed in front of the muscle. There are options for improving it, and it is worth knowing the starting point before deciding.

Sources

• Risks and Complications of Breast Implants. U.S. Food and Drug Administration, updated 14 December 2023. fda.gov. — “Breast implants are not considered lifetime devices”; the risk of complications increases with how long they are worn and some will require more surgery; there is no guarantee of a satisfactory cosmetic result from any further surgery; the life of an implant varies and cannot be predicted; the silent nature of most silicone gel ruptures, the impossibility of detecting them by physical examination, MRI as the most effective method and ultrasound as an acceptable alternative in asymptomatic patients; intracapsular and extracapsular rupture and rupture with gel migration, and the difficulty of removing silicone after a rupture; the Baker grades and the classification of grades III and IV as severe, with the possibility of recurrence after corrective surgery; the two methods of removal, with and without capsulectomy, and en bloc resection; dimpling, hollowing of the chest wall, puckering and sagging after removal without replacement, with significant deformity possible in large implants placed subglandularly; and the warning that some insurers do not cover removal or replacement even where there are complications.
• Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). U.S. Food and Drug Administration. fda.gov. — An express recommendation not to remove implants routinely in patients without symptoms; in patients with confirmed BIA-ALCL, removal of the implant and the surrounding capsule.
• Haas E, et al. Capsular Contracture After Breast Augmentation: A Systematic Review and Meta-Analysis. Aesthetic Surgery Journal Open Forum, 2025. PMID 39989707. — 24 studies; factors associated with capsular contracture by implant surface and plane of placement.

Book your consultation

If you have had implants for years and do not know when your check-ups are due — or if nobody has ever told you which ones — that is a specific, short consultation. At our practice in Valencia we review which implant you have, what follow-up is appropriate and whether there is any real reason to consider a change, which is almost never the date.

Clinical confirmation by the surgeon

Dr Enrique Salmerón González

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4624077

Dr Elena García Vilariño

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4624503